Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1997 3
1998 1
1999 1
2001 1
2008 1
2009 1
2011 2
2012 2
2013 1
2018 1
2019 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group.
Koscielniak E, Klingebiel TH, Peters C, Hermann J, Burdach ST, Bender-Götze C, Müller-Weihrich ST, Treuner J. Koscielniak E, et al. Bone Marrow Transplant. 1997 Feb;19(3):227-31. doi: 10.1038/sj.bmt.1700628. Bone Marrow Transplant. 1997. PMID: 9028550
Patients with primary metastatic or recurrent rhabdomyosarcoma (RMS) have a very poor prognosis. Since high-dose chemotherapy (HDC) +/- TBI was thought to improve survival, many centers performed this therapy using different types of hematopoietic rescue (auto BM or …
Patients with primary metastatic or recurrent rhabdomyosarcoma (RMS) have a very poor prognosis. Since high-dose chemotherapy …
A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology Group.
Baruchel S, Pappo A, Krailo M, Baker KS, Wu B, Villaluna D, Lee-Scott M, Adamson PC, Blaney SM. Baruchel S, et al. Eur J Cancer. 2012 Mar;48(4):579-85. doi: 10.1016/j.ejca.2011.09.027. Epub 2011 Nov 14. Eur J Cancer. 2012. PMID: 22088484 Clinical Trial.
PURPOSE: To determine the toxicity, efficacy and pharmacokinetics of trabectedin given over 24h every 3 weeks to children with recurrent rhabdomyosarcoma, Ewing sarcoma, or non-rhabdomyosarcoma soft tissue sarcomas. ...
PURPOSE: To determine the toxicity, efficacy and pharmacokinetics of trabectedin given over 24h every 3 weeks to children with recurrent …
Efficacy of topotecan plus vincristine and doxorubicin in children with recurrent/refractory rhabdomyosarcoma.
Meazza C, Casanova M, Zaffignani E, Luksch R, Podda M, Favini F, Catania S, Biassoni V, Morosi C, Ferrari A. Meazza C, et al. Med Oncol. 2009;26(1):67-72. doi: 10.1007/s12032-008-9085-8. Epub 2008 Aug 5. Med Oncol. 2009. PMID: 18679836
BACKGROUND: This study investigates the efficacy and the feasibility of a chemotherapy regimen with topotecan plus vincristine and doxorubicin (TVD) given on an individually tailored basis to patients with refractory/recurrent rhabdomyosarcoma (RMS). PATIENTS AND ME …
BACKGROUND: This study investigates the efficacy and the feasibility of a chemotherapy regimen with topotecan plus vincristine and doxorubic …
Recurrent rhabdomyosarcoma after 25 years: a possible association with estrogen and progestogen therapy.
Zacharin M, Waters K, Chow CW, Crock P, McKelvie P. Zacharin M, et al. J Pediatr Hematol Oncol. 1997 Sep-Oct;19(5):477-81. doi: 10.1097/00043426-199709000-00015. J Pediatr Hematol Oncol. 1997. PMID: 9329475
PURPOSE: We describe a patient with a late recurrence of rhabdomyosarcoma and review the relevant literature. PATIENT AND METHODS: Recurrent rhabdomyosarcoma occurred in a young woman 25 years after initial presentation, with the onset of symptoms 3 months after com …
PURPOSE: We describe a patient with a late recurrence of rhabdomyosarcoma and review the relevant literature. PATIENT AND METHODS: Recurr …
Topotecan/carboplatin regimen for refractory/recurrent rhabdomyosarcoma in children: Report from the AIEOP Soft Tissue Sarcoma Committee.
Compostella A, Affinita MC, Casanova M, Milano GM, Scagnellato A, Dall'Igna P, Chiaravalli S, Pierobon M, Manzitti C, Zanetti I, Schiavetti A, Sorbara S, Mura RM, Ruggiero A, Ferrari A, Bisogno G. Compostella A, et al. Tumori. 2019 Apr;105(2):138-143. doi: 10.1177/0300891618792479. Epub 2018 Aug 22. Tumori. 2019. PMID: 30131003
Rhabdomyosarcoma of the ear in childhood. A report from the Intergroup Rhabdomyosarcoma Study-I.
Raney RB Jr, Lawrence W Jr, Maurer HM, Lindberg RD, Newton WA Jr, Ragab AH, Tefft M, Foulkes MA. Raney RB Jr, et al. Cancer. 1983 Jun 15;51(12):2356-61. doi: 10.1002/1097-0142(19830615)51:12<2356::aid-cncr2820511232>3.0.co;2-l. Cancer. 1983. PMID: 6342748 Clinical Trial.
One is alive with regional recurrence at 6.7 years; another developed a contralateral cerebellar astrocytoma 4.4 years from diagnosis and died without evidence of rhabdomyosarcoma 2 months later. The other 13 children died of recurrent rhabdomyosarcoma at 5 to 25 mo …
One is alive with regional recurrence at 6.7 years; another developed a contralateral cerebellar astrocytoma 4.4 years from diagnosis and di …
A phase II trial of high-dose methotrexate in previously untreated children and adolescents with high-risk unresectable or metastatic rhabdomyosarcoma.
Pappo AS, Bowman LC, Furman WL, Rao BN, Kun LE, Jenkins JJ, Crom WR, Luo X, Kaste SC, Avery L, Meyer WH, Shapiro DN, Crist WM. Pappo AS, et al. J Pediatr Hematol Oncol. 1997 Sep-Oct;19(5):438-42. doi: 10.1097/00043426-199709000-00006. J Pediatr Hematol Oncol. 1997. PMID: 9329466 Clinical Trial.
PURPOSE: The outcome for children with advanced-stage rhabdomyosarcoma remains poor with contemporary treatment regimens. Evaluation of new drugs is important to improve clinical outcome. Because methotrexate has shown promising activity in the treatment of patients with …
PURPOSE: The outcome for children with advanced-stage rhabdomyosarcoma remains poor with contemporary treatment regimens. Evaluation of new …
Recurrent alveolar rhabdomyosarcoma with prior surgery and radiotherapy: altered lymphatic drainage limits the reliability of sentinel lymph node biopsy.
Nishida Y, Tsukushi S, Yamada Y, Shimoyama Y, Shido Y, Wasa J, Ishiguro N. Nishida Y, et al. J Pediatr Hematol Oncol. 2011 Jan;33(1):e26-8. doi: 10.1097/MPH.0b013e3181faf857. J Pediatr Hematol Oncol. 2011. PMID: 21102351
Sentinel lymph node biopsy with conventional blue dye alone might be insufficient to assess lymph node status in patients with recurrent rhabdomyosarcoma previously treated with surgery and/or radiotherapy....
Sentinel lymph node biopsy with conventional blue dye alone might be insufficient to assess lymph node status in patients with recurrent …
14 results